Mixed Mesodermal (Mullerian) Tumor
2 clinical trials · Condition
◉ Watch Mixed Mesodermal (Mullerian) Tumor
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer (NCT00954174) | GOG Foundation | 2009-08-17 |
Track Mixed Mesodermal (Mullerian) Tumor automatically
Every clearance here is in the API, with alerts when new ones post.